Business Partners

News

2 August 2017

Medical Devices and the Amendment to the Reimbursement Act

V HTA Symposium in Krakow – Session Recap IV Arcana Institute hosted the V HTA Symposium in Krakow on 29th-30th May 2017, which provided an in-depth view of the many important topics taking place in  more...
28 July 2017

Merging NFZ with ZUS – V HTA Symposium in Krakow

V HTA Symposium in Krakow – Session Recap III Arcana Institute hosted the V HTA Symposium in Krakow on 29th-30th May 2017, which provided an in-depth view of the many important topics taking place  more...
21 July 2017

Rare and Ultra-Rare Diseases – V HTA Symposium in Krakow

V HTA Symposium in Krakow – Session Recap II Arcana Institute hosted the V HTA Symposium in Krakow on 29th-30th May 2017, which provided an in-depth view of the many important topics taking place  more...

Instytut Arcana – why us?

With over a decade of experience, in the past five years alone we have completed 250 HTA dossiers throughout CEE countries, all validated by the appropriate regulatory bodies. Our researchers are experienced in working on international projects in cooperation with our LASER partners from the US, France, Germany, Span and the UK. Every year we participate in about 30 projects carried out for both international companies and foreign public organizations (such as EFSA).

Our understanding of global healthcare trends and requirements enable us to offer full support through the entire reimbursement process to our business partners, which help them reach their business objectives as well as their sustainable goals.

Wide experience in different health care systems and excellent analytical potential which distinguish us from other companies operating in the field of health technology assessment.

 

read more about us